Showing 1 - 20 results of 97 for search '(( ct ((largest decrease) OR (marked decrease)) ) OR ( n ((246 decrease) OR (026 decrease)) ))', query time: 0.43s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Naphthalen-1-yl 2,4,6-trimethyl benzenesulfonate enhances cadmium tolerance in <i>Zea mays</i> by boosting antioxidant defense and photosynthetic efficiency by Cansu Altuntaş (22016082)

    Published 2025
    “…This study investigates whether naphthalene-1-yl 2,4,6-trimethyl benzenesulfonate (NTB) acts as a dual-functional agent by enhancing Cd uptake and reducing toxicity in maize. …”
  5. 5
  6. 6
  7. 7

    Data Sheet 1_Empagliflozin’s cardioenergetic protective effects through PPARα pathway modulation in heart failure.pdf by Hua Wei (60877)

    Published 2025
    “…Post-treatment, MRGlu and glucose uptake decreased markedly in the empagliflozin (EMPG) group, while no significant changes were observed in the fenofibrate (FF) group. …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    (A-H). Case 1: primary subcutaneous facial alveolar echinococcosis. by Louis Bohard (22250661)

    Published 2025
    “…<p><b>(A)</b> Left frontal swelling at diagnosis. <b>(B)</b> Marked regression of the lesion after 6 months of albendazole therapy. …”
  17. 17

    Histogram of the extracted parameters. by Qiuyu Du (20760848)

    Published 2025
    “…</p><p>Results</p><p>Lung volume, aorta dimension and contrast delay were considered as possible confounders but were not selected by forward selection. Logistic regression (n = 93) showed that a less steep contrast gradient (decreasing by 10 Hounsfield unit/%) was associated with a reduction in odds of the following short-term adverse outcomes: 48.1% for intensive care unit admission (odds ratio [OR] = 0.519, 95% confidence interval [CI]: 0.306–0.804), 29.3% for oxygen therapy >24 hours (OR = 0.707, 95% CI: 0.496–0.976), 60.6% for reperfusion therapy (OR = 0.394, 95% CI: 0.178–0.682), 57.5% for vasopressor therapy (OR = 0.425, 95% CI: 0.194–0.741), and 50.2% for PE-related death (OR = 0.498, 95% CI: 0.246–0.915). …”
  18. 18
  19. 19
  20. 20